Aseptic meningitis associated with lamotrigine: Report of two cases [2]

European Journal of Neurology

Volumn 14, Issue 12, 2007, Pages

  Nesseler, N ^a   Polard, E ^a   Arvieux, C ^a   Coquerel, N ^a   Michelet, C ^a   Tattevin, P ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Drug induced aseptic meningitis; Lamotrigine

Indexed keywords

DIDANOSINE; LAMIVUDINE; LAMOTRIGINE; LOPINAVIR; RITONAVIR; VALPROIC ACID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANAMNESIS; ASEPTIC MENINGITIS; CASE REPORT; CEREBROSPINAL FLUID; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPILEPSY; FEMALE; HUMAN; LETTER; LEUKOCYTE COUNT; MALE; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL; TOXOPLASMOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTICONVULSANTS; BLOOD; BLOOD CHEMICAL ANALYSIS; CEREBROSPINAL FLUID; DIAGNOSIS, DIFFERENTIAL; FEMALE; FEVER; HUMANS; MALE; MENINGITIS, ASEPTIC; MENINGITIS, BACTERIAL; MENINGITIS, VIRAL; PHENOBARBITAL; TRIAZINES; VALPROIC ACID;

EID: 36248941875     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2007.01960.x     Document Type: Letter

References (11)

1. Moris G, Garcia-Monco JC. The challenge of drug-induced aseptic meningitis. Archives of Internal Medicine 1999 159: 1185 1194.
2. Jolles S, Sewell WA, Leighton C. Drug-induced aseptic meningitis: diagnosis and management. Drug Safety 2000 22: 215 226.
3. Kepa L, Oczko-Grzesik B, Stolarz W, Sobala-Szczygiel B. Drug-induced aseptic meningitis in suspected central nervous system infections. Journal of Clinical Neuroscience 2005 12: 562 564.
4. Perucca E. Birth defects after prenatal exposure to antiepileptic drugs. Lancet Neurology 2005 4: 781 786.
5. Lanctot KL, Naranjo CA. Comparison of the Bayesian approach and a simple algorithm for assessment of adverse drug events. Clinical Pharmacology and Therapeutics 1995 58: 692 698.
6. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clinical Pharmacology and Therapeutics 1981 30: 239 245.
7. Abdulle S, Hagberg L, Gisslen M. Effects of antiretroviral treatment on blood-brain barrier integrity and intrathecal immunoglobulin production in neuroasymptomatic HIV-1-infected patients. HIV Medicine 2005 6: 164 169.
8. Polis MA, Suzman DL, Yoder CP, et al. Suppression of cerebrospinal fluid HIV burden in antiretroviral naive patients on a potent four-drug antiretroviral regimen. AIDS 2003 17: 1167 1172.
9. Schaub JE, Williamson PJ, Barnes EW, Trewby PN. Multisystem adverse reaction to lamotrigine. Lancet 1994 344: 481.
10. Kilfoyle DH, Anderson NE, Wallis WE, Nicholls DW. Recurrent severe aseptic meningitis after exposure to lamotrigine in a patient with systemic lupus erythematosus. Epilepsia 2005 46: 327 328.
11. Dang CT, Riley DK. Aseptic meningitis secondary to carbamazepine therapy. Clinical Infectious Diseases 1996 22: 729 730.